newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Announces FDA Lifted Clinical Hold on pheNIX Gene Therapy Trial for PKU

- Company Increased Risk-Mitigation Strategies, Including a Steroid-SparingImmunosuppression Regimen - BEDFORD, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (NASDAQ:FIXX), a genetic medicines company, announced today that the U.